Skip to content

The effect of honey intake on blood glucose responses

The effect of honey intake on blood glucose responses - The effect of honey intake on blood glucose responses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059764
Enrollment
28
Registered
2026-02-20
Start date
2025-11-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult

Interventions

Intake of a test food 1- washout period - a test food 2 Dose: 250ml Single ingestion Intake of a test food 2- washout period - a test food 1 Dose: 250ml Single ingestion

Sponsors

Yamada Bee Company, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females, aged 20 to 59 years at the time of providing consent (2) Subjects with a BMI of less than 30 kg/m2 (3) Subjects who are able to provide fingertip blood sample (8 times/day for 3 observation periods) (4) Subjects with normal blood glucose and HbA1c levels based on examinations in the past year, and who have not been advised to visit a hospital (5) Subjects who have provided voluntary, written informed consent after fully understanding the details of the study

Exclusion criteria

Exclusion criteria: (1) Subjects who may develop allergies to the test food (2) Subjects with a history of major surgery in the gastrointestinal tract, such as gastrectomy, gastrointestinal suture, or bowel resection (3) Subjects who have chronic illness or disability in the liver, biliary tract, gastrointestinal tract, circulatory system, kidney, urinary system, psychiatric, nervous and hematological system (4) Subjects who use health foods that contain ingredients that may affect the blood glucose level (unless they can discontinue use at least 1 week prior to the screening examination) (5) Subjects who are routinely taking medicines known to affect blood glucose levels (6) Subjects who are currently taking steroids, protease inhibitors or antipsychotics (7) Subjects who are participating in another clinical trial at the time of screening (8) Subjects who are pregnant, breast-feeding, or planning to become pregnant or breast-feeding during the study period (9) Subjects who are unable to comply with the study requirements (10) Subjects who are judged as ineligible for the subject of this study by investigator

Design outcomes

Primary

MeasureTime frame
Blood glucose level

Countries

Japan

Contacts

Public ContactYukie Nakagawa

Yamada Bee Company, Inc. Functional research section, Institute for Bee Products & Health Science, R&D department

yn2180@yamada-bee.com0868-54-1199

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026